← All trials
NCT02989571
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2016
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- Dec 12, 2016
- Last posted
- Jan 20, 2023
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- MemorialCare Health SystemLead sponsor
- MemorialCare Health SystemReponsible party - principal investigator
- MemorialCare Health SystemSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.